|
1) Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005; 352: 1685-95
|
|
|
|
2) Cybulsky MI, Iiyama K, Li H, et al. A major role for VCAM-1, but not ICAM-1, in early athe-rosclerosis. J Clin Invest. 2001; 107: 1255-62
|
|
|
|
|
|
3) van der Wal AC, Becker AE, van der Loos CM, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994; 89: 36-44
|
|
|
|
|
|
4) Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006; 124: 783-801
|
|
|
|
|
|
5) Moore KJ, Kunjathoor VV, Koehn SL, et al. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not amelio-rate atherosclerosis in hyperlipidemic mice. J Clin Invest. 2005; 115: 2192-201
|
|
|
|
|
|
6) Edfeldt K, Swedenborg J, Hansson GK, et al. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation. 2002; 105: 1158-61
|
|
|
|
|
|
7) Medzhitov, R. Toll-like receptors and innate immunity. Nat Rev Immunol. 2001; 1: 135-45
|
|
|
|
|
|
8) Kurt-Jones EA, Popova L, Kwinn L, et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol. 2000; 1: 398-401
|
|
|
|
|
|
9) Lehr HA, Sagban TA, Ihling C, et al. Immu-nopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hyper-cholesterolemic diet. Circulation. 2001; 104: 914-20
|
|
|
|
|
|
10) Ostos MA, Recalde D, Zakin MM, et al. Impli-cation of natural killer T cells in atherosclerosis development during a LPS-induced chronic inflammation. FEBS Lett. 2002; 519: 23-9
|
|
|
|
|
|
11) Mullick AE, Tobias PS, Curtiss LK. Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest. 2005; 115: 3149-56
|
|
|
|
|
|
12) Smeeth L, Thomas SL, Hall AJ, et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004; 351: 2611-8
|
|
|
|
|
|
13) Michelsen KS, Wong MH, Shah PK, et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipo-protein E. Proc Natl Acad Sci U S A. 2004; 101: 10679-84
|
|
|
|
|
|
14) Naiki Y, Sorrentino R, Wong MH, et al. TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneu-moniae-induced acceleration of atherosclerosis. J Immunol. 2008; 181: 7176-85
|
|
|
|
|
|
15) Matzinger P. The danger model: a renewed sense of self. Science. 2002; 296: 301-5
|
|
|
|
|
|
16) Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol. 2008; 8: 279-89
|
|
|
|
|
|
17) Rock KL, Kono H. The inflammatory response to cell death. Annu Rev Pathol. 2008; 3: 99-126
|
|
|
|
|
|
18) Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol. 1994; 12: 991-1045
|
|
|
|
|
|
19) Liu X, Ukai T, Yumoto H, et al. Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids. Atherosclerosis. 2008; 196: 146-54
|
|
|
|
|
|
20) Bjorkbacka H, Kunjathoor VV, Moore KJ, et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to acti-vation of innate immunity signaling pathways. Nat Med. 2004; 10: 416-21
|
|
|
|
|
|
21) Chen CJ, Kono H, Golenbock D, et al. Identi-fication of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med. 2007; 13: 851-6
|
|
|
|
|
|
22) Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009 27: 519-50
|
|
|
|
|
|
23) Feldmann J, Prieur AM, Quartier P, et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet. 2002; 71: 198-203
|
|
|
|
|
|
24) Martinon F, Petrilli V, Mayor A, et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006; 440: 237-41
|
|
|
|
|
|
25) Kono H, Chen CJ, Ontiveros F, et al. Uric acid promotes an acute inflammatory response to sterile cell death in mice. J Clin Invest. 2010; 120: 1939-49
|
|
|
|
|
|
26) Li H, Ambade A, Re F. Cutting edge: Necrosis activates the NLRP3 inflammasome. J Immunol. 2009; 183: 1528-32
|
|
|
|
|
|
27) Duewell P, Kono H, Rayner KJ, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010; 464: 1357-61
|
|
|
|
|
|
28) Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol. 2009; 7: 99-109
|
|
|
|
|